FDA Seeks Feedback on Distributed and Point-of-Care Drug Manufacturing

F

FDA

Guest
FDA is keenly interested in these technologies because they could potentially provide flexibility for drug manufacturers to enable rapid and localized response to changing demand and increase timely access to quality drugs for U.S. patients.


Baca selengkapnya di : http://www.fda.gov...
 
You must log in or register to reply here.
Top